Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
Citations Over TimeTop 10% of 2015 papers
Abstract
The aetiology of human fibrolamellar hepatocellular carcinomas (hFL-HCCs), cancers occurring increasingly in children to young adults, is poorly understood. We present a transplantable tumour line, maintained in immune-compromised mice, and validate it as a bona fide model of hFL-HCCs by multiple methods. RNA-seq analysis confirms the presence of a fusion transcript (DNAJB1-PRKACA) characteristic of hFL-HCC tumours. The hFL-HCC tumour line is highly enriched for cancer stem cells as indicated by limited dilution tumourigenicity assays, spheroid formation and flow cytometry. Immunohistochemistry on the hFL-HCC model, with parallel studies on 27 primary hFL-HCC tumours, provides robust evidence for expression of endodermal stem cell traits. Transcriptomic analyses of the tumour line and of multiple, normal hepatic lineage stages reveal a gene signature for hFL-HCCs closely resembling that of biliary tree stem cells--newly discovered precursors for liver and pancreas. This model offers unprecedented opportunities to investigate mechanisms underlying hFL-HCCs pathogenesis and potential therapies.
Related Papers
- → Application of comparative functional genomics to identify best-fit mouse models to study human cancer(2004)477 cited
- Mutations and aberrant transcriptions of Stk11 (Lkb1) gene in rat liver tumors.(2011)
- Progress in Liver Cancer Stem Cells(2011)
- Expression of PCAN and RAR-α in hepatocellular carcinoma(2002)
- Pathologic Biomarkers that Indicate the Aggressiveness and Prognosis of Hepatocellular Carcinoma(2020)